FDA.reportPublic FDA data

1 ML givosiran 189 MG/ML Injection

RxCUI
2265716
RxNorm name
1 ML givosiran 189 MG/ML Injection
Display name
1 ML givosiran 189 MG/ML Injection
Full name
1 ML givosiran 189 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GIVLAARIGIVOSIRAN SODIUMAlnylam Pharmaceuticals, Inc.167e663c-11e1-497b-a3fc-951d65d58eaa2025-09-10Warnings, Adverse reactionsExact identifier
rxcui: 2265716

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
167e663c-11e1-497b-a3fc-951d65d58eaagivosiran 189 MG in 1 ML Injection [PSN] · 1 ML givosiran 189 MG/ML Injection [SCD] · givosiran 189 MG per 1 ML Injection [SY]314These highlights do not include all the information needed to use GIVLAARI ® safely and effectively. See full prescribing information for GIVLAARI. GIVLAARI (givosiran) injection, for subcutaneous use Initial U.S. Approval: 201920250910